GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
The fees, which are billed separately from physician’s services, have been around for decades but have sparked nationwide ...
As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.
Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...
The rapid evolution of diabetes research and management calls for a forward-thinking approach that embraces innovation to address the multifaceted ...